Showing results (921-930 of 11,913) with videos related to

Sort By:
Pageof 1,192
The New England Journal of Medicine|September 2, 1999
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis geneA Pietrangelo, G Montosi, A Totaro, et al.
The New England Journal of Medicine|July 29, 1999
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapyA Freifeld, D Marchigiani, T Walsh, et al.
The New England Journal of Medicine|July 29, 1999
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerW V Kern, A Cometta, R De Bock, et al.
The New England Journal of Medicine|July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting InvestigatorsA M Lincoff, R M Califf, D J Moliterno, et al.
The New England Journal of Medicine|July 29, 1999
Measurement of the urinary lactate:creatinine ratio for the early identification of newborn infants at risk for hypoxic-ischemic encephalopathyC C Huang, S T Wang, Y C Chang, et al.
The New England Journal of Medicine|July 29, 1999
The intensity of physicians' work in patient visits--implications for the coding of patient evaluation and management servicesR D Lasker, M S Marquis
The New England Journal of Medicine|September 14, 2000
Foot ulcersB E Sumpio
The New England Journal of Medicine|October 16, 1975
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapyS E Sallan, N E Zinberg, E Frei
The New England Journal of Medicine|September 21, 2000
Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizationsX Jouven, M Zureik, M Desnos, et al.
The New England Journal of Medicine|September 28, 2000
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study GroupL B Saltz, J V Cox, C Blanke, et al.
Pageof 1,192